Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT03849599 | A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis | PHASE1 | COMPLETED | 37 | — | — | Feb 1, 2018 | Feb 1, 2019 | Feb 12, 2020 | - | — |
| Name | Type | Description |
|---|---|---|
| PRV-300 | BIOLOGICAL | Treatment |
| Placebo | BIOLOGICAL | Control |